Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

Q3 2024 Earnings Conference Call November 4, 2024 9:00 AM ETCompany ParticipantsDavid Zaccardelli - President and ...

It comprises of oxygenation, bronchodilation and, if the reactions severity warrants it, administration of systemic corticosteroids.

Overall, cilomilast is well tolerated, with 4 clinical trials encompassing 1151 patients reporting the most common adverse effects to be diarrhea, nausea, dizziness, and headaches. [10,11,12,13 ...